RECRUITINGPhase 3INTERVENTIONAL
Effect of Some Drugs on Liver Fibrosis
Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C
About This Trial
Effect of Some Drugs on Liver Fibrosis
Who May Be Eligible (Plain English)
Who May Qualify:
- chronic hepatitis C
Who Should NOT Join This Trial:
- Acute hepatitis
- Thalassemia
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* chronic hepatitis C
Exclusion Criteria:
* Acute hepatitis
* Thalassemia
Treatments Being Tested
DRUG
Candesartan
Candesartan 8 mg/day
DRUG
Ramipril
ramipril 1.25 mg/day
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt